ASPIRA WOMEN'S HEALTH INC (AWH) Stock Price, Quote, News and Overview
NASDAQ:AWH - Nasdaq - US04537Y2081 - Common Stock - Currency: USD
AWH Quote, Performance and Key Statistics
0.082
-0.01 (-12.49%)
The current stock price of AWH is 0.082 USD. In the past month the price decreased by -30.51%. In the past year, price decreased by -97.65%.
AWH Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 26.96 | 223.47B | ||
| ISRG | INTUITIVE SURGICAL INC | 67.35 | 184.36B | ||
| BSX | BOSTON SCIENTIFIC CORP | 37.74 | 150.72B | ||
| SYK | STRYKER CORP | 29.95 | 139.34B | ||
| MDT | MEDTRONIC PLC | 15.76 | 107.94B | ||
| BDX | BECTON DICKINSON AND CO | 14.74 | 58.89B | ||
| EW | EDWARDS LIFESCIENCES CORP | 29.25 | 44.70B | ||
| IDXX | IDEXX LABORATORIES INC | 38.88 | 35.45B | ||
| RMD | RESMED INC | 25.98 | 34.64B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.24 | 31.33B | ||
| DXCM | DEXCOM INC | 43.43 | 28.10B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 15.84 | 23.53B |
Related stock screener links
About AWH
Company Profile
Aspira Women's Health, Inc. engages in the provision of bio-analytic and diagnostic services. The company is headquartered in Austin, Texas and currently employs 64 full-time employees. The company went IPO on 2000-09-29. The firm's portfolio includes OvaWatch and the Ova1Plus workflow, offered to clinicians as OvaSuite. OvaWatch is used to assess ovarian cancer risk for women with an adnexal mass where their initial clinical assessment indicates the mass is indeterminate or benign. The Ova1Plus workflow is designed to assess the risk of ovarian malignancy in women planning for surgery and uses two tests, Ova1 as the primary test and Overa as a reflex for Ova1 intermediate range results. Its in-development test pipeline includes OvaMDxSM risk assessment, EndoCheck and EndoMDx, which are designed to expand its ovarian cancer portfolio and address the tremendous need for noninvasive diagnostics for endometriosis. EndoCheck is a noninvasive test designed to identify endometriomas.
Company Info
ASPIRA WOMEN'S HEALTH INC
12117 Bee Caves Road Building Three, Suite 100
Austin TEXAS 78738 US
CEO: Valerie B. Palmieri
Employees: 64
Company Website: https://aspirawh.com/
Investor Relations: https://ir.aspirawh.com/
Phone: 15125190400
ASPIRA WOMEN'S HEALTH INC / AWH FAQ
What is the stock price of ASPIRA WOMEN'S HEALTH INC today?
The current stock price of AWH is 0.082 USD. The price decreased by -12.49% in the last trading session.
What is the ticker symbol for ASPIRA WOMEN'S HEALTH INC stock?
The exchange symbol of ASPIRA WOMEN'S HEALTH INC is AWH and it is listed on the Nasdaq exchange.
On which exchange is AWH stock listed?
AWH stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for ASPIRA WOMEN'S HEALTH INC stock?
5 analysts have analysed AWH and the average price target is 5.61 USD. This implies a price increase of 6741.46% is expected in the next year compared to the current price of 0.082. Check the ASPIRA WOMEN'S HEALTH INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is ASPIRA WOMEN'S HEALTH INC worth?
ASPIRA WOMEN'S HEALTH INC (AWH) has a market capitalization of 2.89M USD. This makes AWH a Nano Cap stock.
How many employees does ASPIRA WOMEN'S HEALTH INC have?
ASPIRA WOMEN'S HEALTH INC (AWH) currently has 64 employees.
What are the support and resistance levels for ASPIRA WOMEN'S HEALTH INC (AWH) stock?
ASPIRA WOMEN'S HEALTH INC (AWH) has a resistance level at 0.09. Check the full technical report for a detailed analysis of AWH support and resistance levels.
Is ASPIRA WOMEN'S HEALTH INC (AWH) expected to grow?
The Revenue of ASPIRA WOMEN'S HEALTH INC (AWH) is expected to grow by 79.1% in the next year. Check the estimates tab for more information on the AWH EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy ASPIRA WOMEN'S HEALTH INC (AWH) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of AWH, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of AWH, evaluating the profitability, health, valuation and growth aspects
- ASPIRA WOMEN'S HEALTH INC (AWH) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ASPIRA WOMEN'S HEALTH INC (AWH) Sales and EPS estimates to see what analysts future expectations are.
- ASPIRA WOMEN'S HEALTH INC (AWH) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ASPIRA WOMEN'S HEALTH INC (AWH) Insider and Institutional Ownership to learn about the owners and their transactions.
- ASPIRA WOMEN'S HEALTH INC (AWH) Stock Chart to make your own analysis
- ASPIRA WOMEN'S HEALTH INC (AWH) Latest news and press-releases to stay up to date.
Does ASPIRA WOMEN'S HEALTH INC (AWH) stock pay dividends?
AWH does not pay a dividend.
When does ASPIRA WOMEN'S HEALTH INC (AWH) report earnings?
ASPIRA WOMEN'S HEALTH INC (AWH) will report earnings on 2025-05-13, before the market open.
What is the Price/Earnings (PE) ratio of ASPIRA WOMEN'S HEALTH INC (AWH)?
ASPIRA WOMEN'S HEALTH INC (AWH) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.99).
What is the Short Interest ratio of ASPIRA WOMEN'S HEALTH INC (AWH) stock?
The outstanding short interest for ASPIRA WOMEN'S HEALTH INC (AWH) is 3.24% of its float. Check the ownership tab for more information on the AWH short interest.
AWH Technical Analysis
AWH Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to AWH. AWH may be in some trouble as it scores bad on both profitability and health.
AWH Financial Highlights
Over the last trailing twelve months AWH reported a non-GAAP Earnings per Share(EPS) of -0.99. The EPS increased by 44.5% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -238.46% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
AWH Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 80% to AWH. The Buy consensus is the average rating of analysts ratings from 5 analysts.
For the next year, analysts expect an EPS growth of 46.73% and a revenue growth 79.1% for AWH